Preview

General Reanimatology

Advanced search

The Informative Value of N-Terminal Pro-type B Natriuretic Peptide in Cardiac Surgical Patients with Hypercreatininemia

https://doi.org/10.15360/1813-9779-2011-6-40

Abstract

Objective: to study the informative value of a dramatic increase in the preoperative blood level of the inactive moiety of the precursor of N-terminal pro-type B natriuretic peptide (NT-proBNP) in cardiac surgical patients with hypercreatininemia. Subjects and materials. Twenty-one patients with a preoperative NT-proBNP level of 1000 pg/ml or more, who underwent myocardial revascularization under extracorporeal circulation (ECC), were examined. The patients were divided into groups with normal (up to 120 ^mol/l) (Group 1; n=11) and elevated (Group 2; n=10) creatinine concentrations. The values of circulation were processed after skin incision and at the end of surgery. The clinical features of a perioperative period were analyzed. Results. Creatininemia was 103±3.3 and 183±12.9 ^mol/l in Groups 1 and 2, respectively (p<0.05); NT-proBNP was 1397±139 and 1908±170 pg/ml (p<0.05). EuroSCORE-predicted mortality ran to 9.8±1.6 and 9.1±1.7% (p>0.05). There were no intergroup differences in intraoperative circulatory parameters. The intensity of sympatomimetic therapy after ECC was equal in the identified patient groups and there were either no differences (p>0.05) in the frequency of intra-aortic balloon counterpulsation (18.2 and 10.0%), the length of mechanical ventilation (15±1.5 and 18.7±2.3 hours) and intensive care unit stay (1.8±0.5 and 2.0±0.7 days) in survivors, and inpatient mortality (23.7 and 20.0%) that proved to be substantially higher than the EuroSCORE-predicted one. Regression analysis showed that in the entire group of operated patients, the level of NT-proBNP turned out to be a more significant predictor of inpatient mortality (p=0.012) than EuroSCORE-predicted one (p = 0.04). The similar regularity was characteristic for patients with hypercreatininemia. In the patients with hypercholesterolemia, the EuroSCORE-predicted mortality completely lost its significance (p=0.61) in predicting actual mortality rates. In this group, NT-proBNP showed a predicting trend. Conclusion. The blood NT-proBNP concentration of 1000 pg/ml or more preserves its significance as a high operative risk factor in the presence of myocardial revascularization under ECC in patients with the blood creatinine level of 140—270 ^mol/l. Key words: N-terminal pro-type B natriuretic peptide (NT-proBNP), myocardial revascularization, extracorporeal circulation, hypercreatininemia.

References

1. Козлов И. А., Кричевский Л. А., Шумаков Д. В. и соавт.

2. Козлов И. А., Харламова И. Е.Натрийуретические пептиды: биохимия, физиология, клиническое использование. Общая реаниматология 2009; V (1): 89—97.

3. Козлов И. А., Харламова И. Е.Повышенный уровень натрийурети-ческого пептида B-rara(NT-proBNP) как фактор риска у кардиохи-рургических больных. Общая реаниматология 2010; VI (1): 49—55.

4. Мороз В. В., Никифоров Ю. В., Кричевский Л. А. и соавт.Значение сердечного пептида NT-proBNP в оценке риска реваскуляризации миокарда у больных со сниженной фракцией изгнания левого желудочка. Общая реаниматология 2010; VI (2): 38—42.

5. Vanderheyden M., Bartunek J., Goethals M.Brain and other natri-uretic peptides: molecular aspects. Eur. J. Heart Fail. 2004; 6 (3): 261—268.

6. Linssen G. C, Damman K., Hillege H. L. et al.Urinary N-terminal pro-hormone brain natriuretic peptide excretion in patients with chronic heart failure. Circulation 2009; 120 (1): 35—41.

7. Mosorin M. A., Heikkinen J. J., Pokela M. et al.Immediate and 5-year outcome after coronary artery bypass surgery in very high risk patients (additive EuroSCORE > 10). J. Cardiovasc. Surg. (Torino) 2011; 52 (2): 271—276.

8. Bernstein L. H., Zions M. Y., Haq S. A. et al.Effect of renal function loss on NT-proBNP level variations. Clin. Biochem. 2009; 42 (10—11): 1091—109

9. Srisawasdi P., Vanavanan S., Charoenpanichkit C., Kroll M. H.The effect of renal dysfunction on BNP, NT-proBNP, and their ratio. Am. J. Clin. Pathol. 2010; 133 (1): 14—23.

10. Fincke R., Hochman J. S., Lowe A. M. et al.Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: A report from the SHOCK trial registry. J. Am. Coll. Cardiol. 2004; 44 (2): 340—348.

11. Reyes G., Fores G., Rodrfguez-Abella R. H. et al.NT-proBNP in cardiac surgery: a new tool for the management of our patients? Interact. Cardiovasc. Thorac. Surg. 2005; 4 (3): 242—247.

12. WeberM., Hamm C.Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart 2006; 92 (6): 843—849.

13. Barbosa R. R., Cestari P. F, CapelettiJ. T. et al.Impact of renal failure on in-hospital outcomes after coronary artery bypass surgery. Arq. Bras. Cardiol. 2011; 97 (3): 249—253.

14. Palmer S. C., Endre Z. H., Richards A. M., Yandle T. G.Characterization of NT-proBNP in human urine. Clin. Chem. 2009; 55 (6): 1126—1134.

15. Michielsen E. C., Bakker J. A., Kimmenade R. R. et al.The diagnostic value of serum and urinary NT-proBNP for heart failure. Ann. Clin. Biochem. 2008; 45 (Pt 4): 389—394.

16. Ng L. L., Geeranavar S., Jennings S. C. et al.Diagnosis of heart failure using urinary natriuretic peptides. Clin. Sci. (Lond. ) 2004; 106 (2): 129—133.


Review

For citations:


Burzhunova M.G., Guseva O.G., Rybakov V.Yu., Krichevsky L.A., Kozlov I.A. The Informative Value of N-Terminal Pro-type B Natriuretic Peptide in Cardiac Surgical Patients with Hypercreatininemia . General Reanimatology. 2011;7(6):40. (In Russ.) https://doi.org/10.15360/1813-9779-2011-6-40

Views: 1232


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1813-9779 (Print)
ISSN 2411-7110 (Online)